Terms: = Head and neck cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
16 results:
1. Association between the Preoperative Dietary Antioxidant Index and Postoperative Quality of Life in Patients with Esophageal Squamous Cell Carcinoma: A Prospective Study Based on the ttd Model.
Zhang J; Zhou J; Huang Y; Lin Z; Zhang S; Qiu M; Xiang Z; Hu Z
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447155
[TBL] [Abstract] [Full Text] [Related]
2. Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.
Zhu F; Li F; Xie X; Wu Y; Wang W
Cancer Med; 2023 Jun; 12(12):13290-13299. PubMed ID: 37132252
[TBL] [Abstract] [Full Text] [Related]
3. SEOM-GEMCAD-ttd Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021).
Fernández-Montes A; Alcaide J; Alsina M; Custodio AB; Franco LF; Gallego Plazas J; Gómez-Martín C; Richart P; Rivera F; Martin-Richard M
Clin Transl Oncol; 2022 Apr; 24(4):658-669. PubMed ID: 35347573
[TBL] [Abstract] [Full Text] [Related]
4. Imbalance in DNA repair machinery is associated with BRAF
Lutz BS; Leguisamo NM; Cabral NK; Gloria HC; Reiter KC; Agnes G; Zanella V; Meyer ELS; Saffi J
Mol Cell Endocrinol; 2018 Sep; 472():140-148. PubMed ID: 29229408
[TBL] [Abstract] [Full Text] [Related]
5. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.
Liu C; Wang S; Zeng W; Guo Y; Liu Z; Huang T
Sci Rep; 2017 May; 7(1):1846. PubMed ID: 28500312
[TBL] [Abstract] [Full Text] [Related]
6. Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Zhou F; Zhu M; Wang M; Qiu L; Cheng L; Jia M; Xiang J; Wei Q
J Transl Med; 2016 May; 14(1):154. PubMed ID: 27246611
[TBL] [Abstract] [Full Text] [Related]
7. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
Li F; Wang J; Chen M
Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
[TBL] [Abstract] [Full Text] [Related]
8. Increased expression of ercc2 gene in head and neck cancer is associated with aggressive tumors: a systematic review and case-control study.
Zafeer M; Mahjabeen I; Kayani MA
Int J Biol Markers; 2016 Feb; 31(1):e17-25. PubMed ID: 26659720
[TBL] [Abstract] [Full Text] [Related]
9. Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Deenen MJ; Meulendijks D; Boot H; Legdeur MC; Beijnen JH; Schellens JH; Cats A
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1285-95. PubMed ID: 26499900
[TBL] [Abstract] [Full Text] [Related]
10. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Findlay JM; Middleton MR; Tomlinson I
Ann Oncol; 2015 Apr; 26(4):624-644. PubMed ID: 25214541
[TBL] [Abstract] [Full Text] [Related]
11. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
[TBL] [Abstract] [Full Text] [Related]
12. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
[TBL] [Abstract] [Full Text] [Related]
13. Genetic variants in DNA repair predicts the survival of patients with esophageal cancer.
Lee JM; Yang PW; Yang SY; Chuang TH; Tung EC; Chen JS; Huang PM; Lee YC
Ann Surg; 2011 May; 253(5):918-27. PubMed ID: 21490450
[TBL] [Abstract] [Full Text] [Related]
14. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract] [Full Text] [Related]
15. Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of xpd, XRCC3 and UGT1A1 polymorphisms.
Font A; Salazar R; Maurel J; Taron M; Ramirez JL; Tabernero J; Gallego R; Casado E; Manzano JL; Carcereny E; Guix M; Fernández-Llamazares J; Rosell R
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1075-83. PubMed ID: 18335219
[TBL] [Abstract] [Full Text] [Related]
16. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract] [Full Text] [Related]